Aelin TherapeuticsAelin TherapeuticsAelin Therapeutics
  • HOME
  • TECHNOLOGY
  • PIPELINE
  • ABOUT
  • CAREERS
  • NEWS
  • CONTACT
Press enter to begin your search
Als we niet snel ingrijpen worden standaardingrepen binnenkort problematisch

Als we niet snel ingrijpen worden standaardingrepen binnenkort problematisch

By Heleen24 December 2018General news
No Comments

Els Beirnaert, CEO van Aelin Therapeutics in Z-talk

https://kanaalz.knack.be/talk/als-we-niet-snel-ingrijpen-worden-standaardingrepen-binnenkort-problematisch-22-12-18/video-normal-1409969.html

The Company

Aelin Therapeutics is a privately held Belgian company, founded as a spin-off of the VIB and its partner universities KU Leuven, VUB and UGent. The company has a strong and growing IP portfolio, a scientific and management team with a solid track record and a very reputable investor syndicate.

Company details

T: +32 (0)16/85.27.00

A: Gaston Geenslaan 1
3001 Leuven

BE-0685.688.842

Contact us

© Copyright Aelin Therapeutics | Privacy Policy Website by Turnstone

  • HOME
  • TECHNOLOGY
  • PIPELINE
  • ABOUT
  • CAREERS
  • NEWS
  • CONTACT
This site uses cookies: Read more